Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy.

Front Oncol · 2025 · PMC12497632 · PMID 41059291

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Despite deeper responses in the SPd-60 cohort, as of June 30, 2023, mPFS was numerically longer, however did not reach statistical significance with SPd-40 (18.4 months [95% CI: 6.5, NR]) compared to SPd-60 (9.5 months [95% CI: 7.6, NR]) ( 16 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.